You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Monoclonal Antibody Treatment

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Leuven (REGN15160 (IV), Matching Placebo (IV), REGN15160 (SC))

Active, not recruiting
  • Healthy
  • REGN15160 (IV)
  • +3 more
  • Leuven, Belgium
    Regeneron Study Site
Jan 6, 2023

Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,

Not yet recruiting
  • Metastatic Colorectal Carcinoma
  • +3 more
  • Bevacizumab
  • +11 more
  • (no location specified)
May 9, 2023

Primary Membranous Nephropathy Trial in Beijing (B007)

Not yet recruiting
  • Primary Membranous Nephropathy
  • Beijing, China
    Peking university first hospital
Dec 20, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (procedure, biological, drug)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • (no location specified)
Dec 2, 2022

Solid Tumor and Lymphoma Trial (HLX60)

Not yet recruiting
  • Solid Tumor and Lymphoma
  • (no location specified)
Nov 1, 2022

Non-Malignant Tumor Trial in Seattle (biological, drug, radiation, procedure)

Recruiting
  • Non-Malignant Neoplasm
  • Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 29, 2022

Solid Tumor Trial (GS-4528, Zimberelimab)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Apr 21, 2023

Spinal Cord Injuries Trial in Shanghai (TNFa Monoclonal Antibody, Methylprednisolone, Saline)

Not yet recruiting
  • Spinal Cord Injuries
  • TNFα Monoclonal Antibody
  • +2 more
  • Shanghai, China
    Shanghai Changzheng Hospital
May 4, 2022

Malignant Melanoma, Liver Metastases Trial (Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel)

Not yet recruiting
  • Malignant Melanoma
  • Liver Metastases
  • Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel
  • (no location specified)
Dec 23, 2022

Immunological Pure Red Cell Aplasia Trial (Isatuximab)

Not yet recruiting
  • Immunological Pure Red Cell Aplasia
  • (no location specified)
Sep 26, 2022

Locally Advanced/Metastatic Solid Tumors Trial (PE0116&PE0105)

Not yet recruiting
  • Locally Advanced/Metastatic Solid Tumors
  • (no location specified)
Mar 24, 2023

Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Houston (NTX-1088, Pembrolizumab)

Recruiting
  • Cancer
  • +4 more
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jan 24, 2023

HIV Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (VRC-HIVMAB0115-00-AB)

Recruiting
  • HIV
  • VRC-HIVMAB0115-00-AB
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Gastric Cancer Trial in Shanghai (NK510, Tislelizumab,atezolizumab or Trastuzumab)

Enrolling by invitation
  • Gastric Cancer
  • NK510
  • Tislelizumab，atezolizumab or Trastuzumab
  • Shanghai, China
    Shanghai Tenth People's Hospital
Oct 22, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Duarte

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Copper Cu 64-DOTA-Trastuzumab
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Psoriasis Trial in Shanghai (608 Q2W, 608 Q4W, Placebo)

Not yet recruiting
  • Psoriasis
  • 608 Q2W
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Huanshan Hospital Fudan University
Sep 8, 2022

Colorectal Cancer Trial (Serplulimab + FOLFOXIRI, Radiation therapy)

Not yet recruiting
  • Colorectal Cancer
  • Serplulimab + FOLFOXIRI
  • Radiation therapy
  • (no location specified)
Oct 24, 2023

Monoclonal Antibody Duration of REsponse in MIgraine After

Recruiting
  • Migraine
  • Headache, Migraine
  • Headache calendar completion
  • Valladolid, Spain
    Hospital Clínico Universitario de Valladolid
Jul 15, 2022

Advanced Solid Tumor Trial in Zhengzhou, Linyi (BAT4706 Injection, BAT1308 Injection)

Not yet recruiting
  • Advanced Solid Tumor
  • BAT4706 Injection
  • BAT1308 Injection
  • Zhengzhou, Henan, China
  • +2 more
Nov 14, 2023

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +15 more
  • Bellevue, Nebraska
  • +3 more
Nov 30, 2022

Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Los Angeles, California
  • +4 more
Jul 19, 2022

Antibody-mediated Rejection Trial in Vienna, Berlin (Felzartamab, Placebo)

Recruiting
  • Antibody-mediated Rejection
  • Vienna, Austria
  • +1 more
Aug 23, 2022

Advanced Cancer Trial in Houston (Dasatinib, Bevacizumab, Paclitaxel)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 21, 2022

Solid Tumor, Adult Trial in Australia (IOS-1002, IOS-1002 + PD-1 mAb)

Recruiting
  • Solid Tumor, Adult
  • Clayton, Australia
  • +4 more
Mar 15, 2023

Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal

Not yet recruiting
  • Esophagus Cancer
  • +4 more
  • Intravenous injection of P-IL-2
  • P-IL-2 plus Anti-PD-1 Monoclonal Antibody
  • (no location specified)
Apr 24, 2023